Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cameron Turtle currently holds 37,313 shares of Eidos Therapeutics, Inc. (EIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cameron Turtle has been a net seller of EIDX stock. They have purchased $0 and sold $13.3M worth of shares.
Cameron Turtle's most recent insider trade was on Mar 23, 2026, when they sold 37,313 shares at $0.00 per share.
Cameron Turtle serves as Executive at Eidos Therapeutics, Inc. (EIDX). They have executed 93 insider transactions totaling $13.3M over their tenure at the company.
Cameron Turtle holds the position of Executive at Eidos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Cameron Turtle has shown a selling trading pattern, with $0 in total purchases and $13.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cameron Turtle was on Dec 15, 2020, when they sold $1.3M worth of EIDX shares. This transaction involved 11,445 shares at $112.19 per share.
Cameron Turtle currently owns 37,313 shares of Eidos Therapeutics, Inc. (EIDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cameron Turtle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cameron Turtle has 93 Form 4 filings on record as an insider at Eidos Therapeutics, Inc..
Set alerts for Cameron Turtle and 40,000+ other insiders.